Imviva Biotech to Present Treatment Updates for Leukemia & Anemia at ASH 2025
By Karen Roman Imviva Biotech said it will present its progress in allogenic cell therapy candidates in two oral presentations and five poster presentations at the 67th American Society of Hematology (ASH) Annual Meeting, to be held on December 6-9,...